| |
|
Form Serial Number: |
DA20221116E00187
|
| 1.
Date of relevant event: |
11/11/2022
(dd/mm/yyyy)
|
| 2.
Date when director became aware of the relevant event/ interest in the shares (if later): |
(dd/mm/yyyy)
|
| 3.
Stock code: |
06996 |
| 4.
Name of listed corporation: |
Antengene Corporation Limited |
| 5.
Class of shares: |
Ordinary Shares |
| 6.
Number of issued shares in class: |
660,971,644 |
| 7.
Name of director (English) as printed on HKID Card/Passport: |
| (Surname) |
Mei |
| (Other names) |
Jay |
|
|
|
| 10.
Name of director (Chinese): |
|
| 11.
Chinese Character Code as printed on HKID Card: |
|
| |
| 24.
Details of relevant event: |
|
|
Brief description of relevant event
|
Capacity in which shares were/are held
|
Number of shares bought/sold or involved
|
Currency of transaction |
On Exchange
|
Off Exchange
|
|
Before relevant event
|
After relevant event
|
Highest price (per share)
|
Average price (per share)
|
Average consideration (per share)
|
Consideration code
|
| Long position |
| 11031 | The number of shares in which you are interested has increased because:
you became the holder of, wrote or issued equity derivatives under which (choose one):
you have a right to take the underlying shares |
|
|
| 2501 | Other (you must describe the capacity in the Supplementary Information box) |
|
3,000,000 |
|
|
|
|
|
| Short position |
|
|
|
|
|
|
|
|
|
| |
|
| 25.
Total shares in listed corporation immediately before the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 180,597,994 | 27.32 |
|
| |
| 26.
Total shares in listed corporation immediately after the relevant event: |
| | Total number of shares | Percentage figure (%) |
| Long position | 183,597,994 | 27.78 |
|
| |
| 27.
Capacity in which interests disclosed in Box 26 are held: |
| Code describing capacity | Number of shares |
| |
| 2201 | Interest of corporation controlled by you |
| |
| 2501 | Other (you must describe the capacity in the Supplementary Information box) |
| |
|
| |
| 28.
Further information in derivative interests in listed corporation : |
| Derivatives code |
Exercise period (dd/mm/yyyy) |
Consideration - if derivatives granted by listed corporation |
Number of shares |
| | | Begins | Ends | Currency | Price for grant | Currency | Exercise price | Currency | Price on assignment | |
| Long position | | 4101 | Listed derivatives - Physically settled |
| 19/11/2022 | 22/08/2030 | | | USD | 0.920 | | | 4,000,000 |
| Long position | | 4101 | Listed derivatives - Physically settled |
| 27/08/2023 | 26/08/2031 | | | HKD | 12.560 | | | 268,000 |
| Long position | | 4101 | Listed derivatives - Physically settled |
| 27/08/2024 | 26/08/2031 | | | HKD | 12.560 | | | 201,000 |
| Long position | | 4101 | Listed derivatives - Physically settled |
| 27/08/2025 | 26/08/2031 | | | HKD | 12.560 | | | 201,000 |
| Long position | | 4101 | Listed derivatives - Physically settled |
| 11/11/2023 | 10/11/2032 | | | HKD | 0.000 | | | 750,000 |
| Long position | | 4101 | Listed derivatives - Physically settled |
| 11/11/2024 | 10/11/2032 | | | HKD | 0.000 | | | 498,000 |
| Long position | | 4101 | Listed derivatives - Physically settled |
| 11/11/2025 | 10/11/2032 | | | HKD | 0.000 | | | 501,000 |
| Long position | | 4101 | Listed derivatives - Physically settled |
| 11/11/2026 | 10/11/2032 | | | HKD | 0.000 | | | 501,000 |
|
| |
| 29.
Further information in relation to interests of children under 18 and/or spouse: |
| Child/Spouse | Name of child/spouse | Number of shares |
| | |
|
| |
| 30.
Further information in relation to interests of corporations controlled by Director: |
| Name of controlled corporation | Address and place of incorporation | Name of controlling person | % control | Direct interest (Y/N) | Number of shares |
| JAY MEI 2022 GRAT | N/A | Jay Mei | 100.00 | N | |
| AM & Beyond Trust | N/A | Jay Mei | 100.00 | N | |
| Meiland Pharma Tech SPC | Sertus Chambers, Governors Square, Suite # 5-204, 23 Lime Tree Bay Avenue, P.O. Box 2547, Grand Cayman, KY1-1104, Cayman Islands (Cayman Islands) | JAY MEI 2022 GRAT | 18.61 | Y | |
| Meiland Pharma Tech SPC | Sertus Chambers, Governors Square, Suite # 5-204, 23 Lime Tree Bay Avenue, P.O. Box 2547, Grand Cayman, KY1-1104, Cayman Islands (Cayman Islands) | AM & Beyond Trust | 8.52 | Y | |
| Meiland Pharma Tech SPC | Sertus Chambers, Governors Square, Suite # 5-204, 23 Lime Tree Bay Avenue, P.O. Box 2547, Grand Cayman, KY1-1104, Cayman Islands (Cayman Islands) | Jay Mei | 72.87 | Y | |
|
| |
| 31.
Further information in relation to interests held by Director jointly with another person: |
| Name of joint shareholder | Address | Number of shares |
| | |
|
| |
| 32.
Further information from a director who is a trustee, or beneficiary of a trust, or a person who has set up a Discretionary Trust: |
| Names of Trust | Address | Status code | Number of shares |
| AM & Beyond Trust | Addresses of individuals are not displayed. | | 5102 | Beneficiary of a trust (other than a discretionary interest) |
| |
| JAY MEI 2022 GRAT | Addresses of individuals are not displayed. | | 5102 | Beneficiary of a trust (other than a discretionary interest) |
| |
|
| |
| 33.
Further information from a party to an agreement under Section 317 (Please see Notes for further information required): |
| Names of other parties | Address | Number of shares |
| | |
| Total number of shares in which a director is interested under sections 317 and 318 | |
|
| |
| 34.
Supplementary information: |
Dr. Jay Mei was granted 3,000,000 RSUs on November 11, 2022 in accordance with the resolutions of the Listed Company, 750,000 of which were immediately vested on the same date.
|
| 35.
Log/Serial Number of the previous form: |
|
| 36.
Number of concert party document(s) under section 317 attached/uploaded: |
|
|
Date of filing this Form 3A: |
16/11/2022
(dd/mm/yyyy)
|
| |